List of works - Anne M Fagan

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

scientific article

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

scientific article

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans

scientific article published in March 2006

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

scientific article

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

scholarly article

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

scientific article

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

scientific article published on 8 January 2007

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

scientific article published on May 2015

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

scientific article

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model

scientific article published on 20 October 2005

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

scientific article

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

scientific article published on 04 September 2013

APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42

scientific article

Sleep Quality and Preclinical Alzheimer Disease

scientific article published on May 1, 2013

CSF biomarker variability in the Alzheimer's Association quality control program

scientific article published on May 2013

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

scientific article

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly

scientific article published on February 2009

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

scientific article

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease

scientific article

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

scientific article

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease

scientific article

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

scientific article

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease

scientific article

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

scientific article published on July 2011

ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy

scientific article published on 20 September 2017

Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia

scientific article published on December 2006

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease

scientific article

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

scientific article

Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease

scientific article published in April 2002

Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease

scientific article published on 28 September 2006

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

scientific article

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

scientific article (publication date: 19 April 2011)

Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein

scientific article published on November 1996

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

scientific article published on 10 April 2013

Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model

scientific article published in June 2000

Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.

scientific article

Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report

scientific article published on December 2009

Functional connectivity and graph theory in preclinical Alzheimer's disease

scientific article published on 18 October 2013

Exercise and Alzheimer's disease biomarkers in cognitively normal older adults

scientific article

Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition

scientific article published on May 2012

Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network

scientific article (publication date: October 2012)

Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy

scientific article published on 25 July 2016

Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR.

scientific article published in October 1997

Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type

scientific article published on May 2009

Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease

scientific article

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.

scientific article

Suspected non-Alzheimer disease pathophysiology--concept and controversy

scientific article

Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice

scientific article

Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.

scientific article published in May 1998

TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo

scientific journal article

List of works by Anne M Fagan

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42

Sleep Quality and Preclinical Alzheimer Disease

CSF biomarker variability in the Alzheimer's Association quality control program

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy

Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease

Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model

Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.

Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report

Functional connectivity and graph theory in preclinical Alzheimer's disease

Exercise and Alzheimer's disease biomarkers in cognitively normal older adults

Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition

Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network

Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy

Differential dependency of cutaneous mechanoreceptors on neurotrophins, trk receptors, and P75 LNGFR.

Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type

Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.

Suspected non-Alzheimer disease pathophysiology--concept and controversy

Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice

Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.

TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo